Miransertib, CAS [[1313881-70-7]]

Produktübersicht

• Artikelname: Miransertib, CAS [[1313881-70-7]]
• Artikelnummer: BYT-ORB1304175
• Hersteller Artikelnummer: orb1304175
• Alternativnummer: BYT-ORB1304175-1, BYT-ORB1304175-2, BYT-ORB1304175-5, BYT-ORB1304175-1, BYT-ORB1304175-10, BYT-ORB1304175-25, BYT-ORB1304175-50, BYT-ORB1304175-100, BYT-ORB1304175-200
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: AKT inhibitor 2, Akt1, AKT1-E17K, Akt2, Akt3, Akt, anti-tumor, anti-proliferative, ARQ092, ARQ-092, ARQ 092, Inhibitor, inhibit, Miransertib, Parasite, p-Akt, p-PRAS40, Protein kinase B, PKB

Produktbeschreibung

Miransertib (ARQ-092) is a potent, selective, and orally available allosteric inhibitor of Akt. It is widely used in preclinical research to investigate oncogenic PI3K/Akt pathway signaling, demonstrating activity in both in vitro cellular assays and in vivo xenograft models for cancers and overgrowth syndromes.

Produkteigenschaften

• Molekulargewicht: 432.52
• Reinheit: 99.93% (May vary between batches)
• CAS Nummer: [1313881-70-7]
• Formel: C27H24N6
• Target-Kategorie: Parasite,Akt

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.31 mM),DMSO:12.75 mg/mL (29.48 mM)